Marcelo Matiello is a Neurology physician affiliated with Massachusetts General Hospital. OpenAlex indexes 69 publications with 4,474 citations (h-index 25).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
75 Francis St
Boston, MA 021156106
Telephone
203-789-3947Provider last certified this registry record 2 Apr 2026.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year20258 payments
- TG Therapeutics, Inc.Program year20253 payments
- Genentech USA, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
80.8%Gabapentinoids34.7%Gabapentin57%Pregabalin43%Part D<11 patientsOther antiepileptics8.4%Topiramate100%Part D<11 patients+ 10 more classes in this area
Cancer & immunology
9.1%Other immunostimulants5.9%Copaxone100%Part D<11 patientsCD20-directed Cytolytic Antibody3.2%Kesimpta Pen100%Part D<11 patientsMusculoskeletal
6.9%Central alpha-2 Adrenergic Agonist6.9%Tizanidine Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Effectiveness of immunotherapies in relapsing myelin oligodendrocyte glycoprotein antibody-associated disease
Multiple Sclerosis Journal
2024 - Case 15-2023: A 33-Year-Old Man with Paresthesia of the Arms and Legs
New England Journal of Medicine
2023 - Safety and Feasibility of an Emergency Department–to–Outpatient Pathway for Patients With TIA and Nondisabling Stroke
Neurology Clinical Practice
2023
Similar KOLs
Other experts from the same institution or the same specialty.
James Januzzi, MD
Massachusetts General Hospital
Maurizio Fava, MD
Massachusetts General Hospital
Steven Greenberg, MD
Massachusetts General Hospital
David Scadden, MD
Massachusetts General Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”